BioCentury
ARTICLE | Company News

Sequitur, Rigel functional genomics deal

August 22, 2001 7:00 AM UTC

Sequitur (Natick, Mass.) granted RIGL access to its antisense functional genomics technology, including antisense compounds and sequence selection and transfection methods. The companies also will joi...